W.A.I.T. Indicator

Estudo FIFARMA W.A.I.T. Indicator 2026 sobre o acesso à inovação na América Latina

FIFARMA W.A.I.T. Indicator 2026: do tempo de espera à oportunidade de avançar

FIFARMA W.A.I.T. Indicator 2026 study on access to innovation in Latin America

FIFARMA W.A.I.T. Indicator 2026: from waiting time to an opportunity to move forward

Estudio FIFARMA W.A.I.T. Indicator 2026 sobre el tiempo de acceso a medicamentos innovadores en América Latina.

FIFARMA W.A.I.T. Indicator 2026: del tiempo de espera a la oportunidad de avanzar

04e2a44a-3b35-47cc-922d-0136296c

Patient WAIT Indicator 2025: ¿Cómo están los tiempos de espera en los sistemas de salud de Latinoamérica? 

Diverse group of people sitting together in hospital waiting room

Latin American patients must wait an average of 4.7 years to access innovative or cutting-edge treatments

DALL·E 2024-08-28 11.29.03 - A realistic and photographic image of advanced medical treatments. The image shows a close-up of various medical items representing innovative medicat

Reliance: homologación regulatoria para acelerar el acceso a medicamentos 

pexels-julie-viken-593451

What is the waiting time to access new cancer medications in Latin America?

Smiling Cancer Patient Looking at test results

FIFARMA launches the second version of the W.A.I.T. Indicator Survey measuring the waiting time to access innovative drugs in LATAM

pexels-daniel-frank-305565

WAIT Indicator: responsible pragmatism in measuring access to new technologies in Latin America

Search

Recent posts

How investment in health drives the development of Latin America
How Health Investment Drives Latin America's Development
Como o investimento em saúde impulsiona o desenvolvimento de América Latina
Como o investimento em saúde impulsiona o desenvolvimento da América Latina
Cómo la inversión en salud impulsa el desarrollo de América Latina
Cómo la inversión en salud impulsa el desarrollo de América Latina